Guarantor (Tables)

12 Months Ended

Dec. 31, 2013

Condensed Consolidating Financial Information

Condensed Consolidating Balance Sheet - December 31, 2013 (In thousands)

						Guarantor		Non-Guarantor		Consolidating		Total
				Parent Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Assets
Current assets:
	Cash and cash equivalents			$	6,710	$	-	$	44,130	$	-	$	50,840
	Accounts receivable, net				-		-		105,072		-		105,072
	Supplies inventory				33		-		18,381		-		18,414
	Deferred income taxes				3,097		-		-		-		3,097
	Prepaid and other current assets				23,993		-		13,971		(4,362)		33,602
		Total current assets			33,833		-		181,554		(4,362)		211,025
Property and equipment, net					9,829		-		160,066		-		169,895
Investments in unconsolidated affiliates and long-term notes receivable					1,484,974		1,453,596		-		(2,922,178)		16,392
Goodwill and other intangible assets, net					20,684		-		978		1,758,970		1,780,632
			Total assets	$	1,549,320	$	1,453,596	$	342,598	$	(1,167,570)	$	2,177,944
Liabilities and Equity
Current liabilities:
	Current portion of long-term debt			$	10,714	$	-	$	10,130	$	-	$	20,844
	Accounts payable				1,972		-		29,487		(3,958)		27,501
	Other accrued liabilities				27,419		-		14,510		(404)		41,525
		Total current liabilities			40,105		-		54,127		(4,362)		89,870
Long-term debt					561,429		-		53,246		(31,377)		583,298
Deferred income taxes					176,020		-		-		-		176,020
Other long-term liabilities					7,569		-		17,934		-		25,503
Noncontrolling interests – redeemable					-		-		63,704		113,993		177,697
Equity:
		Total AmSurg Corp. equity			764,197		1,453,596		114,671		(1,568,267)		764,197
		Noncontrolling interests – non-redeemable			-		-		38,916		322,443		361,359
		Total equity			764,197		1,453,596		153,587		(1,245,824)		1,125,556
			Total liabilities and equity	$	1,549,320	$	1,453,596	$	342,598	$	(1,167,570)	$	2,177,944

Condensed Consolidating Balance Sheet - December 31, 2012 (In thousands)

						Guarantor		Non-Guarantor		Consolidating		Total
				Parent Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Assets
Current assets:
	Cash and cash equivalents			$	7,259	$	-	$	39,139	$	-	$	46,398
	Accounts receivable, net				-		-		96,752		-		96,752
	Supplies inventory				-		-		18,406		-		18,406
	Deferred income taxes				3,088		-		-		-		3,088
	Prepaid and other current assets				19,342		-		13,160		(4,965)		27,537
		Total current assets			29,689		-		167,457		(4,965)		192,181
Property and equipment, net					9,199		-		157,413		-		166,612
Investments in unconsolidated affiliates and long-term notes receivable					1,413,061		1,381,596		-		(2,783,383)		11,274
Goodwill and other intangible assets, net					21,311		-		1,206		1,652,002		1,674,519
			Total assets	$	1,473,260	$	1,381,596	$	326,076	$	(1,136,346)	$	2,044,586
Liabilities and Equity
Current liabilities:
	Current portion of long-term debt			$	5,357	$	-	$	12,050	$	-	$	17,407
	Accounts payable				1,379		-		26,035		(3,905)		23,509
	Other accrued liabilities				29,380		-		15,177		(1,060)		43,497
		Total current liabilities			36,116		-		53,262		(4,965)		84,413
Long-term debt					599,423		-		52,747		(31,465)		620,705
Deferred income taxes					137,648		-		-		-		137,648
Other long-term liabilities					10,585		-		15,387		-		25,972
Noncontrolling interests – redeemable					-		-		61,939		113,443		175,382
Equity:
		Total AmSurg Corp. equity			689,488		1,381,596		108,412		(1,490,008)		689,488
		Noncontrolling interests – non-redeemable			-		-		34,329		276,649		310,978
		Total equity			689,488		1,381,596		142,741		(1,213,359)		1,000,466
			Total liabilities and equity	$	1,473,260	$	1,381,596	$	326,076	$	(1,136,346)	$	2,044,586

Condensed Consolidating Statement of Earnings and Comprehensive Income

Condensed Consolidating Statement of Earnings and Comprehensive Income - Year Ended December 31, 2013 (In thousands)

							Guarantor		Non-Guarantor		Consolidating		Total
					Parent Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Revenues					$	24,167	$	-	$	1,072,694	$	(17,518)	$	1,079,343
Operating expenses:
	Salaries and benefits					61,038		-		272,619		(467)		333,190
	Supply cost					-		-		157,771		-		157,771
	Other operating expenses					22,660		-		217,068		(17,051)		222,677
	Depreciation and amortization					3,186		-		29,842		-		33,028
		Total operating expenses				86,884		-		677,300		(17,518)		746,666
Gain on deconsolidation						2,237		2,237		-		(2,237)		2,237
Equity in earnings of unconsolidated affiliates						204,962		204,962		-		(406,773)		3,151
		Operating income				144,482		207,199		395,394		(409,010)		338,065
Interest expense						27,282		-		2,256		-		29,538
	Earnings from continuing operations before income taxes					117,200		207,199		393,138		(409,010)		308,527
Income tax expense						48,239		-		1,515		-		49,754
	Net earnings from continuing operations					68,961		207,199		391,623		(409,010)		258,773
	Net earnings (loss) from discontinued operations					3,742		-		(971)		-		2,771
		Net earnings				72,703		207,199		390,652		(409,010)		261,544
Less net earnings attributable to noncontrolling interests:
	Net earnings from continuing operations					-		-		186,120		-		186,120
	Net earnings from discontinued operations					-		-		2,721		-		2,721
		Total net earnings attributable to noncontrolling interests				-		-		188,841		-		188,841
			Net earnings attributable to AmSurg Corp. common shareholders		$	72,703	$	207,199	$	201,811	$	(409,010)	$	72,703
Amounts attributable to AmSurg Corp. common shareholders:
	Earnings from continuing operations, net of income tax				$	68,961	$	207,199	$	205,503	$	(409,010)	$	72,653
	Discontinued operations, net of income tax					3,742		-		(3,692)		-		50
			Net earnings attributable to AmSurg Corp. common shareholders		$	72,703	$	207,199	$	201,811	$	(409,010)	$	72,703

Net earnings and comprehensive income, net of income tax					$	72,703	$	207,199	$	390,652	$	(409,010)	$	261,544
	Less comprehensive income attributable to noncontrolling interests					-		-		188,841		-		188,841
		Comprehensive income attributable to AmSurg Corp.
				common shareholders	$	72,703	$	207,199	$	201,811	$	(409,010)	$	72,703

Condensed Consolidating Statement of Earnings and Comprehensive Income - Year Ended December 31, 2012 (In thousands)

							Guarantor		Non-Guarantor		Consolidating		Total
					Parent Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Revenues					$	19,907	$	-	$	918,176	$	(14,901)	$	923,182
Operating expenses:
	Salaries and benefits					54,895		-		235,618		(450)		290,063
	Supply cost					-		-		131,055		-		131,055
	Other operating expenses					20,499		-		186,977		(14,451)		193,025
	Depreciation and amortization					2,860		-		26,990		-		29,850
		Total operating expenses				78,254		-		580,640		(14,901)		643,993
Equity in earnings of unconsolidated affiliates						178,137		178,137		-		(354,710)		1,564
		Operating income				119,790		178,137		337,536		(354,710)		280,753
Interest expense						14,803		-		2,164		-		16,967
	Earnings from continuing operations before income taxes					104,987		178,137		335,372		(354,710)		263,786
Income tax expense						40,810		-		1,554		-		42,364
	Net earnings from continuing operations					64,177		178,137		333,818		(354,710)		221,422
	Net (loss) earnings from discontinued operations					(1,614)		-		3,835		-		2,221
		Net earnings				62,563		178,137		337,653		(354,710)		223,643
Less net earnings attributable to noncontrolling interests:
	Net earnings from continuing operations					-		-		159,187		-		159,187
	Net earnings from discontinued operations					-		-		1,893		-		1,893
		Total net earnings attributable to noncontrolling interests				-		-		161,080		-		161,080
			Net earnings attributable to AmSurg Corp. common shareholders		$	62,563	$	178,137	$	176,573	$	(354,710)	$	62,563
Amounts attributable to AmSurg Corp. common shareholders:
	Earnings from continuing operations, net of income tax				$	64,177	$	178,137	$	174,631	$	(354,710)	$	62,235
	Discontinued operations, net of income tax					(1,614)		-		1,942		-		328
			Net earnings attributable to AmSurg Corp. common shareholders		$	62,563	$	178,137	$	176,573	$	(354,710)	$	62,563

Net earnings and comprehensive income, net of income tax					$	62,563	$	178,137	$	337,653	$	(354,710)	$	223,643
	Less comprehensive income attributable to noncontrolling interests					-		-		161,080		-		161,080
		Comprehensive income attributable to AmSurg Corp.
				common shareholders	$	62,563	$	178,137	$	176,573	$	(354,710)	$	62,563

Condensed Consolidating Statement of Earnings and Comprehensive Income - Year Ended December 31, 2011 (In thousands)

							Guarantor		Non-Guarantor		Consolidating		Total
					Parent Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Revenues					$	11,253	$	-	$	768,823	$	(8,001)	$	772,075
Operating expenses:
	Salaries and benefits					42,739		-		196,358		(359)		238,738
	Supply cost					-		-		101,364		-		101,364
	Other operating expenses					19,468		-		156,521		(7,642)		168,347
	Depreciation and amortization					2,487		-		23,158		-		25,645
		Total operating expenses				64,694		-		477,401		(8,001)		534,094
Equity in earnings of unconsolidated affiliates						152,409		152,409		-		(304,205)		613
		Operating income				98,968		152,409		291,422		(304,205)		238,594
Interest expense						13,195		-		2,132		-		15,327
	Earnings from continuing operations before income taxes					85,773		152,409		289,290		(304,205)		223,267
Income tax expense						33,806		-		1,167		-		34,973
	Net earnings from continuing operations					51,967		152,409		288,123		(304,205)		188,294
	Net (loss) earnings from discontinued operations					(1,970)		-		3,790		-		1,820
		Net earnings				49,997		152,409		291,913		(304,205)		190,114
Less net earnings attributable to noncontrolling interests:
	Net earnings from continuing operations					-		-		138,269		-		138,269
	Net earnings from discontinued operations					-		-		1,848		-		1,848
		Total net earnings attributable to noncontrolling interests				-		-		140,117		-		140,117
			Net earnings attributable to AmSurg Corp. common shareholders		$	49,997	$	152,409	$	151,796	$	(304,205)	$	49,997
Amounts attributable to AmSurg Corp. common shareholders:
	Earnings from continuing operations, net of income tax				$	51,967	$	152,409	$	149,854	$	(304,205)	$	50,025
	Discontinued operations, net of income tax					(1,970)		-		1,942		-		(28)
			Net earnings attributable to AmSurg Corp. common shareholders		$	49,997	$	152,409	$	151,796	$	(304,205)	$	49,997

Net earnings					$	49,997	$	152,409	$	291,913	$	(304,205)	$	190,114
Other comprehensive income, net of income tax:
	Unrealized gain on interest rate swap, net of income tax					515		-		-		-		515
		Comprehensive income, net of income tax				50,512		152,409		291,913		(304,205)		190,629
	Less comprehensive income attributable to noncontrolling interests					-		-		140,117		-		140,117
		Comprehensive income attributable to AmSurg Corp.
				common shareholders	$	50,512	$	152,409	$	151,796	$	(304,205)	$	50,512

Condensed Consolidating Cash Flow Statement

Condensed Consolidating Statement of Cash Flows - Year Ended December 31, 2013 (In thousands)

			Parent		Guarantor		Non-Guarantor		Consolidating		Total
			Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Cash flows from operating activities:
		Net cash flows provided by operating activities	$	45,127	$	208,773	$	426,572	$	(347,648)	$	332,824
Cash flows from investing activities:
	Acquisition of interests in surgery centers and related transactions			-		(74,288)		-		694		(73,594)
	Acquisition of property and equipment			(3,693)		-		(25,163)		-		(28,856)
	Proceeds from sale of interests in surgery centers			-		3,553		-		-		3,553
	Other			-		159		-		-		159
		Net cash flows used in investing activities		(3,693)		(70,576)		(25,163)		694		(98,738)
Cash flows from financing activities:
	Proceeds from long-term borrowings			152,700		-		9,504		-		162,204
	Repayment on long-term borrowings			(188,081)		-		(14,002)		-		(202,083)
	Distributions to owners, including noncontrolling interests			-		(138,875)		(392,922)		347,648		(184,149)
	Changes in intercompany balances with affiliates, net			88		-		(88)		-		-
	Other financing activities, net			(6,690)		678		1,090		(694)		(5,616)
		Net cash flows used in financing activities		(41,983)		(138,197)		(396,418)		346,954		(229,644)
Net increase (decrease) in cash and cash equivalents				(549)		-		4,991		-		4,442
Cash and cash equivalents, beginning of year				7,259		-		39,139		-		46,398
Cash and cash equivalents, end of year			$	6,710	$	-	$	44,130	$	-	$	50,840

Condensed Consolidating Statement of Cash Flows - Year Ended December 31, 2012 (In thousands)

			Parent		Guarantor		Non-Guarantor		Consolidating		Total
			Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Cash flows from operating activities:
		Net cash flows provided by (used in) operating activities	$	(83,605)	$	182,851	$	379,257	$	(182,851)	$	295,652
Cash flows from investing activities:
	Acquisition of interests in surgery centers and related transactions			(90,029)		(280,189)		-		92,830		(277,388)
	Acquisition of property and equipment			(3,681)		-		(25,183)		-		(28,864)
	Proceeds from sale of interests in surgery centers			-		7,309		-		-		7,309
		Net cash flows used in investing activities		(93,710)		(272,880)		(25,183)		92,830		(298,943)
Cash flows from financing activities:
	Proceeds from long-term borrowings			560,000		-		5,566		-		565,566
	Repayment on long-term borrowings			(381,220)		-		(12,944)		-		(394,164)
	Distributions to owners, including noncontrolling interests			-		-		(345,792)		182,851		(162,941)
	Capital contributions			-		90,029		-		(90,029)		-
	Changes in intercompany balances with affiliates, net			(2,666)		-		2,666		-		-
	Other financing activities, net			(70)		-		3,381		(2,801)		510
		Net cash flows provided by (used in) financing activities		176,044		90,029		(347,123)		90,021		8,971
Net increase (decrease) in cash and cash equivalents				(1,271)		-		6,951		-		5,680
Cash and cash equivalents, beginning of year				8,530		-		32,188		-		40,718
Cash and cash equivalents, end of year			$	7,259	$	-	$	39,139	$	-	$	46,398

Condensed Consolidating Statement of Cash Flows - Year Ended December 31, 2011 (In thousands)

			Parent		Guarantor		Non-Guarantor		Consolidating		Total
			Issuer		Subsidiaries		Subsidiaries		Adjustments		Consolidated

Cash flows from operating activities:
		Net cash flows provided by (used in) operating activities	$	(67,911)	$	151,558	$	311,334	$	(151,558)	$	243,423
Cash flows from investing activities:
	Acquisition of interests in surgery centers and related transactions			(84,597)		(243,429)		-		88,803		(239,223)
	Acquisition of property and equipment			(2,858)		-		(19,312)		-		(22,170)
	Proceeds from sale of interests in surgery centers			-		7,274		(248)		-		7,026
		Net cash flows used in investing activities		(87,455)		(236,155)		(19,560)		88,803		(254,367)
Cash flows from financing activities:
	Proceeds from long-term borrowings			281,100		-		7,769		-		288,869
	Repayment on long-term borrowings			(118,100)		-		(11,007)		-		(129,107)
	Distributions to owners, including noncontrolling interests			-		-		(290,282)		151,558		(138,724)
	Capital contributions			-		84,597		-		(84,597)		-
	Changes in intercompany balances with affiliates, net			(178)		-		178		-		-
	Other financing activities, net			(3,609)		-		4,292		(4,206)		(3,523)
		Net cash flows provided by (used in) financing activities		159,213		84,597		(289,050)		62,755		17,515
Net increase in cash and cash equivalents				3,847		-		2,724		-		6,571
Cash and cash equivalents, beginning of year				4,683		-		29,464		-		34,147
Cash and cash equivalents, end of year			$	8,530	$	-	$	32,188	$	-	$	40,718